05/30/13 - 08:00 AM EDT
Biodel shares should move higher ahead of insulin trial results in the third quarter.
05/21/13 - 08:00 AM EDT
One trader believes Rockwell shares will rise into clinical trial results expected in July.
05/14/13 - 10:16 AM EDT
The market overreacted to the resignation of Synta's R&D chief.
03/04/13 - 07:00 AM EST
Ziopharm is an example of a stock with clinical trial results that can be traded realtively safely.
02/13/13 - 07:00 AM EST
Three factors that will cause Dynavax shares to gain as get closer to the approval of its Hep B vaccine.
01/31/13 - 06:03 AM EST
I expect traders will get an opportunity to profit from increased focus on Titan through March.
01/22/13 - 08:32 AM EST
Look at A.P. Pharma as a trade, not as a long-term investment, says trader Mark Messier.
12/19/12 - 07:00 AM EST
Alexza is setting up as a classic biotech run-down stock, says trader Mark Messier.
12/11/12 - 08:29 AM EST
Anacor will be releasing phase III results for a toenail fungus drug in January.
12/05/12 - 08:00 AM EST
FDA expected to issue approval decision on orphan drug Ravicti on Jan. 23.